Effects and mechanisms of the secondary structure on the antimicrobial activity and specificity of antimicrobial peptides

J Pept Sci. 2015 Jul;21(7):561-8. doi: 10.1002/psc.2767. Epub 2015 Mar 30.

Abstract

A 15-mer cationic α-helical antimicrobial peptide HPRP-A1 was used as the parent peptide to study the effects of peptide secondary structure on the biophysical properties and biological activities. Without changing the amino acid composition of HPRP-A1, we designed two α-helical peptides with either higher or lower helicity compared with the parent peptide, a β-sheet peptide and a random coiled peptide using de novo design approach. The secondary structures were confirmed by circular dichroism spectroscopy. The three α-helical peptides exhibited comparable antibacterial activities, but their hemolytic activity varied from extreme hemolysis to no hemolysis, which is correlated with their helicity. The β-sheet peptide shows poor antibacterial and strong hemolytic activities. More interestingly, the random coil peptide shows no antibacterial activity against Gram-negative bacteria, weak antibacterial activity against Gram-positive bacteria, and extremely weak hemolytic activity. Bacterial membrane permeabilization was also testified on peptides with different secondary structures. Tryptophan fluorescence experiment revealed that the peptide binding preference to the lipid vesicles for mimicking the prokaryotic or eukaryotic membranes was consistent with their biological activities. With the de novo design approach, we proved that it is important to maintain certain contents of amphipathic secondary structure for a desirable biological activity. We believe that the de novo design approach of relocation of the amino acids within a template sequence could be an effective approach in optimizing the specificity of an antimicrobial peptide.

Keywords: antimicrobial peptide; mechanism of action; secondary structure; specificity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Anti-Bacterial Agents / chemical synthesis*
  • Anti-Bacterial Agents / pharmacology
  • Antimicrobial Cationic Peptides / chemical synthesis*
  • Antimicrobial Cationic Peptides / pharmacology
  • Bacillus subtilis / drug effects
  • Bacillus subtilis / growth & development
  • Drug Design*
  • Erythrocytes / cytology
  • Erythrocytes / drug effects
  • Escherichia coli / drug effects
  • Escherichia coli / growth & development
  • Hemolysis / drug effects
  • Humans
  • Hydrophobic and Hydrophilic Interactions
  • Klebsiella pneumoniae / drug effects
  • Klebsiella pneumoniae / growth & development
  • Microbial Sensitivity Tests
  • Molecular Sequence Data
  • Protein Binding
  • Protein Stability
  • Protein Structure, Secondary
  • Pseudomonas aeruginosa / drug effects
  • Pseudomonas aeruginosa / growth & development
  • Solid-Phase Synthesis Techniques / methods*
  • Staphylococcus / drug effects
  • Staphylococcus / growth & development
  • Static Electricity
  • Structure-Activity Relationship
  • Unilamellar Liposomes / chemistry

Substances

  • Anti-Bacterial Agents
  • Antimicrobial Cationic Peptides
  • Unilamellar Liposomes